Vivos Therapeutics Inc (VVOS)

$1.24 -0.06 (-4.62%)
Market Cap 12.98M
Revenue (ttm) 15.03M
Net Income (ttm) -11.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -74.12%
Debt to Equity Ratio 3.45
Volume 216,000
Avg Vol 128,012
Day's Range N/A - N/A
Shares Out 10.47M
Stochastic %K 16%
Beta 6.94
Analysts Sell
Price Target $5.00

Company Profile

Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children....

Industry: Medical Devices
Sector: Healthcare
Phone: 844 672 4357
Address:
7921 Southpark Plaza, Suite 210, Littleton, United States
Giovannirs3
Giovannirs3 Mar. 13 at 8:44 PM
$VVOS ❤️
0 · Reply
Giovannirs3
Giovannirs3 Mar. 13 at 8:43 PM
$VVOS ❤️
0 · Reply
fibtrader99
fibtrader99 Mar. 13 at 7:58 PM
$VVOS born in QE and ZIRP and will die without it, it seems
1 · Reply
Giovannirs3
Giovannirs3 Mar. 13 at 5:45 PM
$VVOS 🤣🤣🤣🤣
0 · Reply
Giovannirs3
Giovannirs3 Mar. 13 at 5:44 PM
$VVOS Could it be worth less? Yes!
0 · Reply
Giovannirs3
Giovannirs3 Mar. 13 at 5:20 PM
$VVOS new all-time lows you have to. ....
0 · Reply
Loopi
Loopi Mar. 13 at 4:59 PM
$VVOS @ACInvestorBlog never believe this idiot big lost made in $PSQH from 2 now 0.6 VVOS bought 4 now 1.29 and more. If you want to lose in market follow him.
2 · Reply
Giovannirs3
Giovannirs3 Mar. 13 at 4:36 PM
$VVOS 👇
0 · Reply
Giovannirs3
Giovannirs3 Mar. 13 at 4:35 PM
$VVOS 🤣
0 · Reply
Loopi
Loopi Mar. 13 at 3:47 PM
$VVOS low will not stop until reach $0.77
0 · Reply
Latest News on VVOS
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth's Groundbreaking FDA-Cleared Allergy and Sleep Technologies

Feb 5, 2026, 8:45 AM EST - 5 weeks ago

Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth's Groundbreaking FDA-Cleared Allergy and Sleep Technologies

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter

Feb 3, 2026, 6:23 AM EST - 5 weeks ago

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter

CERT ZLAB

Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds

Jan 20, 2026, 5:31 PM EST - 7 weeks ago

Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds

Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds

Jan 16, 2026, 8:00 AM EST - 2 months ago

Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds

Vivos Therapeutics, Inc. (VVOS) Discusses Strategic Business Model Pivot and Transition in Sleep Apnea Treatment Approach Transcript

Dec 16, 2025, 4:29 PM EST - 3 months ago

Vivos Therapeutics, Inc. (VVOS) Discusses Strategic Business Model Pivot and Transition in Sleep Apnea Treatment Approach Transcript

Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan

Dec 16, 2025, 8:45 AM EST - 3 months ago

Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan

Vivos Therapeutics, Inc. (VVOS) Q3 2025 Earnings Call Transcript

Nov 19, 2025, 8:33 PM EST - 4 months ago

Vivos Therapeutics, Inc. (VVOS) Q3 2025 Earnings Call Transcript

Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025

Nov 19, 2025, 4:20 PM EST - 4 months ago

Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025

Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call

Nov 19, 2025, 8:30 AM EST - 4 months ago

Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call

Vivos Therapeutics, Inc. (VVOS) Shareholder/Analyst Call Prepared Remarks Transcript

Nov 4, 2025, 1:36 PM EST - 4 months ago

Vivos Therapeutics, Inc. (VVOS) Shareholder/Analyst Call Prepared Remarks Transcript

Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device

Sep 30, 2025, 8:30 AM EDT - 5 months ago

Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device

Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment

Sep 17, 2025, 8:30 AM EDT - 6 months ago

Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment

Vivos Therapeutics, Inc. (VVOS) Q2 2025 Earnings Call Transcript

Aug 22, 2025, 3:08 PM EDT - 7 months ago

Vivos Therapeutics, Inc. (VVOS) Q2 2025 Earnings Call Transcript

Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update

Aug 19, 2025, 4:20 PM EDT - 7 months ago

Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update

Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call

Aug 19, 2025, 8:30 AM EDT - 7 months ago

Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call

New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children

Jun 26, 2025, 8:30 AM EDT - 9 months ago

New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children

Vivos Therapeutics, Inc. (VVOS) Q1 2025 Earnings Call Transcript

May 15, 2025, 7:31 PM EDT - 10 months ago

Vivos Therapeutics, Inc. (VVOS) Q1 2025 Earnings Call Transcript

Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call

May 14, 2025, 9:15 AM EDT - 10 months ago

Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call

Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada

Apr 16, 2025, 8:30 AM EDT - 11 months ago

Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada

Vivos Therapeutics, Inc. (VVOS) Q4 2024 Earnings Call Transcript

Apr 1, 2025, 12:18 AM EDT - 1 year ago

Vivos Therapeutics, Inc. (VVOS) Q4 2024 Earnings Call Transcript

Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update

Mar 31, 2025, 4:20 PM EDT - 1 year ago

Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update

Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call

Mar 28, 2025, 8:30 AM EDT - 1 year ago

Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call

Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Dec 23, 2024, 8:00 AM EST - 1 year ago

Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Vivos Therapeutics, Inc. (VVOS) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 11:31 PM EST - 1 year ago

Vivos Therapeutics, Inc. (VVOS) Q3 2024 Earnings Call Transcript

Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call

Nov 13, 2024, 5:00 PM EST - 1 year ago

Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call

Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association

Oct 8, 2024, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association

Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring

Sep 18, 2024, 7:00 AM EDT - 1 year ago

Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring

Vivos Therapeutics, Inc. (VVOS) Q2 2024 Earnings Call Transcript

Aug 15, 2024, 2:05 PM EDT - 1 year ago

Vivos Therapeutics, Inc. (VVOS) Q2 2024 Earnings Call Transcript

Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update

Aug 14, 2024, 4:05 PM EDT - 1 year ago

Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update

Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call

Aug 14, 2024, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call

Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model

Jun 27, 2024, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model

Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance

Jun 12, 2024, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance

Vivos Therapeutics, Inc. (VVOS) Q1 2024 Earnings Call Transcript

May 17, 2024, 9:02 PM EDT - 1 year ago

Vivos Therapeutics, Inc. (VVOS) Q1 2024 Earnings Call Transcript

Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update

May 14, 2024, 4:05 PM EDT - 1 year ago

Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update

Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call

May 14, 2024, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call

Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement

Apr 9, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement

Vivos Therapeutics, Inc. (VVOS) Q4 2023 Earnings Call Transcript

Mar 28, 2024, 11:10 PM EDT - 2 years ago

Vivos Therapeutics, Inc. (VVOS) Q4 2023 Earnings Call Transcript

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update

Mar 28, 2024, 4:05 PM EDT - 2 years ago

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update

Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call

Mar 28, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call

Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities

Feb 6, 2024, 7:30 AM EST - 2 years ago

Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities

Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company's Proprietary Oral Medical Devices to Treat Severe OSA

Jan 8, 2024, 7:30 AM EST - 2 years ago

Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company's Proprietary Oral Medical Devices to Treat Severe OSA

Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”

Dec 11, 2023, 7:30 AM EST - 2 years ago

Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”

Vivos Therapeutics' stock soars as sleep apnea device gets regulatory clearance

Nov 29, 2023, 11:09 AM EST - 2 years ago

Vivos Therapeutics' stock soars as sleep apnea device gets regulatory clearance

US FDA clears Vivos Therapeutics' oral device treatment for sleep apnea

Nov 29, 2023, 7:44 AM EST - 2 years ago

US FDA clears Vivos Therapeutics' oral device treatment for sleep apnea

Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea

Nov 29, 2023, 7:30 AM EST - 2 years ago

Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea

Vivos Therapeutics, Inc. (VVOS) Q3 2023 Earnings Call Transcript

Nov 17, 2023, 7:12 PM EST - 2 years ago

Vivos Therapeutics, Inc. (VVOS) Q3 2023 Earnings Call Transcript

Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update

Nov 14, 2023, 4:05 PM EST - 2 years ago

Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update

Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call

Nov 9, 2023, 4:30 PM EST - 2 years ago

Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call

Vivos Therapeutics Closes $4 Million Private Placement

Nov 2, 2023, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Closes $4 Million Private Placement

Vivos Therapeutics Announces Reverse Stock Split

Oct 26, 2023, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Announces Reverse Stock Split

Giovannirs3
Giovannirs3 Mar. 13 at 8:44 PM
$VVOS ❤️
0 · Reply
Giovannirs3
Giovannirs3 Mar. 13 at 8:43 PM
$VVOS ❤️
0 · Reply
fibtrader99
fibtrader99 Mar. 13 at 7:58 PM
$VVOS born in QE and ZIRP and will die without it, it seems
1 · Reply
Giovannirs3
Giovannirs3 Mar. 13 at 5:45 PM
$VVOS 🤣🤣🤣🤣
0 · Reply
Giovannirs3
Giovannirs3 Mar. 13 at 5:44 PM
$VVOS Could it be worth less? Yes!
0 · Reply
Giovannirs3
Giovannirs3 Mar. 13 at 5:20 PM
$VVOS new all-time lows you have to. ....
0 · Reply
Loopi
Loopi Mar. 13 at 4:59 PM
$VVOS @ACInvestorBlog never believe this idiot big lost made in $PSQH from 2 now 0.6 VVOS bought 4 now 1.29 and more. If you want to lose in market follow him.
2 · Reply
Giovannirs3
Giovannirs3 Mar. 13 at 4:36 PM
$VVOS 👇
0 · Reply
Giovannirs3
Giovannirs3 Mar. 13 at 4:35 PM
$VVOS 🤣
0 · Reply
Loopi
Loopi Mar. 13 at 3:47 PM
$VVOS low will not stop until reach $0.77
0 · Reply
bninawhile
bninawhile Mar. 13 at 2:00 PM
$VVOS anyone have any ideas on how things are going ?
2 · Reply
bninawhile
bninawhile Mar. 13 at 1:50 PM
$VVOS I am losing patience. I suppose it should hade Been long ago. I understand growth but I don’t understand why I stay before it is evident 🤬
0 · Reply
TickerBR
TickerBR Mar. 13 at 1:49 PM
$VVOS do something!
0 · Reply
Loopi
Loopi Mar. 13 at 11:11 AM
$VVOS Stay away from this if you want lose your money buy it lol. Investors been suffering and more suffering is coming downs 👋
0 · Reply
Giovannirs3
Giovannirs3 Mar. 12 at 10:26 PM
$VVOS 👍
0 · Reply
Giovannirs3
Giovannirs3 Mar. 12 at 10:25 PM
$VVOS 👇
0 · Reply
Idiotinvestur
Idiotinvestur Mar. 12 at 8:36 PM
$VVOS I sure miss the musk guy with his fancy lines lmao
1 · Reply
Loopi
Loopi Mar. 12 at 8:30 PM
$VVOS owners sold everything by now and waiting for RS or P Offering
0 · Reply
Giovannirs3
Giovannirs3 Mar. 12 at 8:06 PM
$VVOS 👇🚆
0 · Reply
Giovannirs3
Giovannirs3 Mar. 12 at 8:05 PM
$VVOS 👍
0 · Reply
oklnd
oklnd Mar. 12 at 4:33 PM
$VVOS looks like $0.7 around the corner
0 · Reply
kemsma62
kemsma62 Mar. 12 at 3:30 PM
$VVOS The number of shortable shares available decreased from 1.5 million to 1 million within a single week according my IBKR account 👇
0 · Reply